Ori. HC: ‘Online RTI Portal’ Launched by Orissa High Court  ||  Del HC: In Delhi, Giving Monthly Pension of Rs.3000 to Building & Construction Workers is Very Small  ||  Del HC: Oil Manufac. Restrained from Using ‘Vigoura’ Mark, in Trademark Infringement Case by Pfizer  ||  SC: HC’s Decision Allowing Amendment of Cheque Date Mentioned in Complaint, Set Aside  ||  Del. HC: If Accused Discharged/Acquitted under PMLA, Properties Attached Shall be Released  ||  Bom. HC: For Issuing Reopening Notice After Three Years, Sanctioning Authority has to be PCCIT  ||  Del. HC: Delhi Govt. to Frame Policy for Compensation to Victims of Chinese Manjha  ||  Del HC: Stay on Delhi Govt’s Circular Asking Private Unaided Schools to Get Sanction Before Fee Hike  ||  SC: Stamp Duty Can be Imposed by State on Insurance Policies Executed Within State  ||  SC: IO to Make Clear & Complete Entries in Chargesheet, Role Played by Each Accused to be Mentioned    

Delhi HC Refuses Interim Relief to Sun Pharma Against Mylan Lab on Oxaliplatin Trademark Case - (13 Feb 2017)

Delhi High Court has refused to provide Sun Pharmaceuticals any interim relief in their trademark infringement case against rival drug manufacturer Mylan Laboratories for production of cancer medication Oxaliplatin.

Tags : DELHI HIGH COURT   MYLAN LABORATORIES   OXALIPLATIN  

Share :        

Disclaimer | Copyright 2024 - All Rights Reserved